CHICAGO, Nov. 14, 2010 /PRNewswire/ –WHAT:You are invited to
demo a new tool for personalized preventive medicine called
CardioHealth® Station from Panasonic Healthcare Co., Ltd.
Currently applying for FDA clearance, this comprehensive risk
assessment tool, includes a powerful ultrasound engine, offering
real-time detection of the thickness of the C-IMT and detects
plaque in the carotid artery. This is the first comprehensive
solution for screening and unlike anything else out there. It
cuts out most of the time consuming steps, making this a
potentially 5-minute (not a 30 minute) exam. It also gathers
all the relevant data and produces a report to help the doctor
explain the findings to the patient. Experts are available to meet
to demo the device, which is currently pending FDA clearance.WHY:
This device is designed to help doctors in screening for early
detection of high risk patients in the asymptomatic population. It
was found in a recent multi-institution study that certain patients
can be reclassified from “Low or Intermediate Risk” to “High Risk”
by looking at the carotid-intima media thickness and the presence
of plaque in that patient. This device will enable rapid
detection of thickened carotid arteries. The innovative automation
technology in the CardioHealth® Station enables testing that
used to be difficult and impractical to do on a mass basis. The
device is operator-independent, provides real-time report and aims
to help reduce overall healthcare costs. Patient-Specific Benefits:
Improves the speed of screening – the exam is expected to
take approximately 5 minutes or less. Reduces interpretation time,
so the report can be quickly made and the doctor can show the
patient any problems that are detected and disc
‘/>”/>